Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

PPIs match surgery in gastroesophageal reflux

Proton pump inhibitors are as effective as surgery in managing gastroesophageal reflux disease, shows the latest report from the US Agency for Healthcare Research and Quality.

News image

fiogf49gjkf04

The US Agency for Healthcare Research and Quality reports treatments for chronic uncomplicated gastroesophageal reflux disease.

The report reviews the effectiveness of medical treatments used by Medicare, Medicaid, and the State Children's Health Insurance Program.

The review was developed by the Tufts New England Medical Center in Boston, Massachusetts.

This review is the first to compares treatment by reviewing existing studies and comparing the outcomes.

The reviewers defined gastroesophageal reflux disease as heartburn or acid regurgitation at least once a week.

The report analyzed randomized and non-randomized comparative studies, recent meta-analyses and cohort studies.

PPIs relieved symptoms of reflux disease as effectively as fundoplication surgery
US Agency for Healthcare Research and Quality

The studies assessed the use of over the counter drugs, proton pump inhibitors (PPIs), fundoplication surgery, and endoscopic procedures.

The report showed that proton pump inhibitors were as effective as fundoplication surgery in relieving the symptoms of reflux disease.

Proton pump inhibitors were also as effective as fundoplication surgery in reducing exposure to esophageal acid, and improving patients' quality of life.

Only a few studies had directly compared these approaches, however, and the total number of patients studied was small.

The review found significant differences in clinical effectiveness between different proton pump inhibitors.

However, the differences noted were modest and the report found the clinical implications unclear.

The evidence showed that the drugs and surgery had similar long term effects in preventing the development of Barrett's esophagus or esophageal adenocarcinoma.

The review found that over the counter H2 receptor antagonist drugs were less effective than proton pump inhibitors.

Over the counter H2 receptor antagonists were, however, associated with fewer side effects, including headache, diarrhoea, and abdominal pain.

The report also noted that surgery was sometimes used to reduce the need for patients to take drugs.

The report showed that 10% to 65% of patients had to resume their use of drugs after having had surgery.

Carolyn Clancy, director of the agency, commented, “This report takes a new step by asking not merely which treatments can be effective, but how treatments compare with one another.”

“It will provide a useful balanced source for obtaining the best scientific information to help select the right treatment for the patient.”

“However, reviews do not constitute treatment recommendations and do not include cost considerations.”

“Randomized controlled trials with long term follow-up comparing laparoscopic fundoplication with proton pump inhibitors to assess the relative benefits and harms of each approach are needed.”

“More efficacy and safety data are also needed with new endoscopic approaches tested against sham procedures.”

AHRQ 2005: 13 December, Effective Health Care Report
12 January 2006

Go to top of page Email this page Email this page to a colleague

 23 November 2017 
Distance travelling for rectal cancer outcomes
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Pharmacological management of GERD
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 21 November 2017 
Prepregnancy obesity and maternal mortality
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us